Oncoloxía médica
Servizo
Instituto de Investigación Sanitaria Aragón
Zaragoza, EspañaPublicacións en colaboración con investigadores/as de Instituto de Investigación Sanitaria Aragón (2)
2020
-
Exploiting oxidative phosphorylation to promote the stem and immunoevasive properties of pancreatic cancer stem cells
Nature Communications, Vol. 11, Núm. 1
2019
-
Phase III evaluating the addition of fulvestrant (F) to anastrozole (A) as adjuvant therapy in postmenopausal women with hormone receptor-positive HER2-negative (HR+/HER2−) early breast cancer (EBC): results from the GEICAM/2006–10 study
Breast Cancer Research and Treatment, Vol. 177, Núm. 1, pp. 115-125